595
Participants
Start Date
June 2, 1995
Primary Completion Date
May 3, 2004
Study Completion Date
December 21, 2009
dexamethasone
40 mg daily for four days given orally and repeated every 28 days should commence on day 29 of the twelfth cycle of induction therapy.
melphalan
9 mg/m2 daily for 4 days given orally on an empty stomach every 4 weeks
prednisone
100 mg daily for 4 days given orally on a full stomach with each cycle of melphalan
St. Mary's/Duluth Clinic Health System, Duluth
Tom Baker Cancer Center - Calgary, Calgary
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna
British Columbia Cancer Agency, Vancouver
Providence Health Care - Vancouver, Vancouver
British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria
Moncton Hospital, Moncton
Doctor Leon Richard Oncology Centre, Moncton
Saint John Regional Hospital, Saint John
Newfoundland Cancer Treatment and Research Foundation, St. John's
Nova Scotia Cancer Centre, Halifax
William Osler Health Centre, Brampton
Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton
Kingston Regional Cancer Centre, Kingston
Cancer Care Ontario-London Regional Cancer Centre, London
Trillium Health Centre, Mississauga
Credit Valley Hospital, Mississauga
Southlake Regional Health Centre, Newmarket
Lakeridge Health Oshawa, Oshawa
Algoma District Medical Group, Sault Ste. Marie
Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines
Toronto East General Hospital, Toronto
Toronto Sunnybrook Regional Cancer Centre, Toronto
St. Michael's Hospital - Toronto, Toronto
Toronto General Hospital, Toronto
Princess Margaret Hospital, Toronto
Humber River Regional Hospital, Weston
Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor
Queen Elizabeth Hospital, PEI, Charlottetown
CHUS-Hopital Fleurimont, Fleurimont
Hopital Charles Lemoyne, Greenfield Park
McGill University, Montreal
Hopital de L'Enfant Jesus, Québec
Hopital du Saint-Sacrement, Quebec, Québec
Allan Blair Cancer Centre, Regina
Lead Sponsor
NCIC Clinical Trials Group
NETWORK